A prospective development and evaluation of a 2D convolutional neural network-based auto-segmentation model for cervical cancer radiotherapy.

IF 2.2 Q3 ONCOLOGY
Sidharth Satish Menon, Mahak Gupta, Aakriti Bhardwaj, Srinidhi G Chandraguthi, Jayashree Np, Umesh Velu, Anshul Singh, Ankita Mehta, Srinivasan Vijayakumar, Lavanya Gurram, Chaitra Raghuram, Roshan David Jathanna, Shirley Lewis
{"title":"A prospective development and evaluation of a 2D convolutional neural network-based auto-segmentation model for cervical cancer radiotherapy.","authors":"Sidharth Satish Menon, Mahak Gupta, Aakriti Bhardwaj, Srinidhi G Chandraguthi, Jayashree Np, Umesh Velu, Anshul Singh, Ankita Mehta, Srinivasan Vijayakumar, Lavanya Gurram, Chaitra Raghuram, Roshan David Jathanna, Shirley Lewis","doi":"10.1186/s43046-026-00382-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Accurate delineation of target volumes and organs at risk (OAR) is essential in radiotherapy planning for cervical cancer. Deep learning (DL)-based auto-segmentation has the potential to improve contouring efficiency and workflow. This study reports the prospective development and internal validation of a DL-based auto-segmentation model- Deep contour (DC) for cervical cancer radiotherapy.</p><p><strong>Methods: </strong>In this prospective single-institution study, a 2-dimensional convolutional neural network based on the LinkNet architecture, DC, was trained on 190 computed tomography (CT) datasets for abdominal and pelvic OARs and 90 cervical cancer datasets for target volumes. Independent validation was performed on 20 CT datasets. Model performance was evaluated using dice similarity coefficient (DSC), Jaccard Index (JI), 95th percentile Hausdorff distance (HD95), average symmetric surface distance (ASSD), and surface dice coefficient (NSD). Expert internal and external radiation oncologists qualitatively explored clinical acceptability using a Likert scale, and segmentation time was compared with manual contouring.</p><p><strong>Results: </strong>The DC demonstrated the greatest geometric performance for the femur (DSC 0.92 ± 0.03; NSD 0.94 ± 0.04), bowel bag (DSC 0.89 ± 0.03; NSD 0.77 ± 0.12), and bladder (DSC 0.88 ± 0.14; NSD 0.87 ± 0.12). Among the target volumes, the inguinal nodal clinical target volume (CTVn_inguinal) achieved the greatest agreement (DSC 0.77 ± 0.04; NSD 0.76 ± 0.07). Moderate performance was observed for the rectum (DSC 0.75 ± 0.16), liver (DSC 0.73 ± 0.21), and pelvic nodal clinical target volume (CTVn_pelvis) (DSC 0.60 ± 0.10), whereas lower performance was observed for anatomically complex structures such as the duodenum, anal canal, common bile duct, pancreas, and pelvic vessels. Clinical evaluation of two cases revealed a Likert score of III-IV for key pelvic organs, such as the bladder, femur, pelvic bowel bag, rectum, and sigmoid. Auto-segmentation significantly reduced the segmentation time from 77 min to 5 s per dataset (p < 0.001).</p><p><strong>Conclusions: </strong>This prospective validation demonstrates that DC auto-segmentation model can achieve acceptable geometric performance congruent across multiple abdominal and pelvic OARs and reasonable geometric performance for the elective inguinal CTV volume. Further validation on larger datasets and evaluation of clinical workflow integration are warranted.</p><p><strong>Registry: </strong>CTRI, TRN: CTRI/2024/02/063055, Registration date: February 22, 2024.</p>","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":"38 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13373109/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-026-00382-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Accurate delineation of target volumes and organs at risk (OAR) is essential in radiotherapy planning for cervical cancer. Deep learning (DL)-based auto-segmentation has the potential to improve contouring efficiency and workflow. This study reports the prospective development and internal validation of a DL-based auto-segmentation model- Deep contour (DC) for cervical cancer radiotherapy.

Methods: In this prospective single-institution study, a 2-dimensional convolutional neural network based on the LinkNet architecture, DC, was trained on 190 computed tomography (CT) datasets for abdominal and pelvic OARs and 90 cervical cancer datasets for target volumes. Independent validation was performed on 20 CT datasets. Model performance was evaluated using dice similarity coefficient (DSC), Jaccard Index (JI), 95th percentile Hausdorff distance (HD95), average symmetric surface distance (ASSD), and surface dice coefficient (NSD). Expert internal and external radiation oncologists qualitatively explored clinical acceptability using a Likert scale, and segmentation time was compared with manual contouring.

Results: The DC demonstrated the greatest geometric performance for the femur (DSC 0.92 ± 0.03; NSD 0.94 ± 0.04), bowel bag (DSC 0.89 ± 0.03; NSD 0.77 ± 0.12), and bladder (DSC 0.88 ± 0.14; NSD 0.87 ± 0.12). Among the target volumes, the inguinal nodal clinical target volume (CTVn_inguinal) achieved the greatest agreement (DSC 0.77 ± 0.04; NSD 0.76 ± 0.07). Moderate performance was observed for the rectum (DSC 0.75 ± 0.16), liver (DSC 0.73 ± 0.21), and pelvic nodal clinical target volume (CTVn_pelvis) (DSC 0.60 ± 0.10), whereas lower performance was observed for anatomically complex structures such as the duodenum, anal canal, common bile duct, pancreas, and pelvic vessels. Clinical evaluation of two cases revealed a Likert score of III-IV for key pelvic organs, such as the bladder, femur, pelvic bowel bag, rectum, and sigmoid. Auto-segmentation significantly reduced the segmentation time from 77 min to 5 s per dataset (p < 0.001).

Conclusions: This prospective validation demonstrates that DC auto-segmentation model can achieve acceptable geometric performance congruent across multiple abdominal and pelvic OARs and reasonable geometric performance for the elective inguinal CTV volume. Further validation on larger datasets and evaluation of clinical workflow integration are warranted.

Registry: CTRI, TRN: CTRI/2024/02/063055, Registration date: February 22, 2024.

基于二维卷积神经网络的宫颈癌放疗自动分割模型的前瞻性开发与评价。
背景:准确描绘靶体积和危险器官(OAR)在宫颈癌放疗计划中至关重要。基于深度学习(DL)的自动分割具有提高轮廓效率和工作流程的潜力。本研究报告了一种基于dl的宫颈癌放疗自动分割模型——深度轮廓(DC)的前瞻性发展和内部验证。方法:在这项前瞻性单机构研究中,基于LinkNet架构(DC)的二维卷积神经网络在190个腹部和盆腔桨的计算机断层扫描(CT)数据集和90个宫颈癌数据集上进行训练。对20个CT数据集进行独立验证。采用骰子相似系数(DSC)、Jaccard指数(JI)、第95百分位Hausdorff距离(HD95)、平均对称表面距离(ASSD)和表面骰子系数(NSD)评价模型性能。专家内部和外部放射肿瘤学家用李克特量表定性地探讨临床可接受性,并将分割时间与人工轮廓进行比较。结果:DC对股骨(DSC 0.92±0.03;NSD 0.94±0.04)、肠袋(DSC 0.89±0.03;NSD 0.77±0.12)、膀胱(DSC 0.88±0.14;NSD 0.87±0.12)几何表现最好。靶体积中,腹股沟淋巴结临床靶体积(ctvn_腹股沟)一致性最大(DSC 0.77±0.04;NSD 0.76±0.07)。直肠(DSC 0.75±0.16)、肝脏(DSC 0.73±0.21)和盆腔淋巴结临床靶体积(ctvn_骨盆)(DSC 0.60±0.10)表现中等,而十二指肠、肛管、胆总管、胰腺和盆腔血管等解剖复杂结构表现较差。2例患者的临床评价显示,膀胱、股骨、盆腔肠袋、直肠、乙状结肠等盆腔关键器官的Likert评分为III-IV分。自动分割将每个数据集的分割时间从77分钟减少到5秒(p)。结论:该前瞻性验证表明,DC自动分割模型可以在多个腹部和骨盆桨上获得可接受的几何性能一致性,并且可以在选择性腹股沟CTV体积上获得合理的几何性能。进一步验证更大的数据集和评估临床工作流程的整合是必要的。注册号:CTRI, TRN: CTRI/2024/02/063055,注册日期:2024年2月22日。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
46
审稿时长
11 weeks
期刊介绍: As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书